Inside Town Hall Ventures’ new $440M fund

Town Hall Ventures launched its fourth fund, targeting $440 million to back startups using AI to improve healthcare access and outcomes for underserved populations.

Editor's Pick

Top Story Inside Town Hall Ventures' New $440M Fund Town Hall Ventures launched its fourth fund, targeting $440 million to back startups using AI to improve healthcare access and outcomes for underserved populations. Sponsored Rethinking The Entry Point to Healthcare in America: Collaboration in Communities Presented by DaVita Healthcare in the U.S. today exists in a complex, fragmented and costly system, and the people this system is designed for deserve a holistic approach to best address their individual health needs. Learn More.

Featured News

How the Stigma Around Male Infertility Can Be Reduced At the HLTH conference in Las Vegas, Colton Underwood and fertility experts highlighted the need to break the stigma around male infertility, urging greater awareness, testing and support to recognize it as a men's health issue as much as a women's one. Startup Expedition Medicines Launches to Learn Nature's Rules for Binding Elusive Proteins Flagship Pioneering's newest startup is Expedition Medicines, a company whose artificial intelligence-driven technology platform analyzes the human proteome to learn the chemistry of binding small molecules to protein targets long considered "undruggable." Expedition already has a cancer drug R&D alliance with Pfizer. Rural Health Transformation Program: What States and Counties Need to Know to Optimize New Funding With closures accelerating and communities already losing access to care, the countdown to FY 2026 is not far off. States, providers and technology partners that act now will define the future of rural health for decades; those that delay may leave billions untapped and lives at risk.  Redefining Clinical Oncology Trials: How Agile Site Networks Accelerate Novel Cancer Therapies Site networks can play a pivotal role in aligning sponsors, sites, and investigators toward shared goals in oncology clinical trials, but they are not one-size-fits-all. Sponsors must carefully vet site networks to validate that they will deliver strategic value for each individual study.    Big Bets, Long Bets: Investing in the Power of Ideas With science funding catapulted into the cultural conversation more than ever in the last year, it faces a critical inflection point. There is an opportunity to design a path forward that builds stability in the short term and opens doors in the long term for foundational and transformational science and technology solutions that will benefit our planet and its people.

Video   Virtual OUD Treatment Is Proving Valuable A report from the Peterson Health Technology Institute found that virtual opioid use disorder companies are just as effective as standard in-person treatment — and they can improve retention. For a long time, the OUD treatment community believed that care needed to be delivered in person, noted Caroline Pearson, an executive director at Peterson Health Technology Institute. However, particularly since the pandemic, virtual care has proven to be effective and convenient, especially in place where there aren't many providers.

Resources

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care Choosing the wrong EMR can slow your practice down. This guide helps healthcare teams compare options, avoid costly pitfalls, and choose a platform that improves care, compliance, and patient experience. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe